Catalent
CTLT
#1737
Rank
C$15.91 B
Marketcap
C$87.70
Share price
0.00%
Change (1 day)
12.11%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): C-$8.56

According to Catalent's latest financial reports the company's current EPS (TTM) is C-$8.74. In 2023 the company made an earnings per share (EPS) of C-$9.39 a decrease over its 2022 EPS that were of C$3.14.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$8.56-8.9%
2023C-$9.39-399.56%
2022C$3.14-30.58%
2021C$4.5279.67%
2020C$2.51114.12%
2019C$1.17-15%
2018C$1.3875.44%
2017C$0.79-22.97%
2016C$1.02-59.56%
2015C$2.53282.05%
2014C$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
C-$0.46-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.04-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C-$8.23-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
C-$2.04-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA